Phillips-Medisize

Phillips Medisize is a global leader in the design, development, and manufacturing of innovative drug delivery, diagnostic, and medtech devices for the healthcare industry.

Founded in 1964 and headquartered in Hudson, Wisconsin, Phillips Medisize operates as a part of Molex, a global electronics leader. The company specialises in creating solutions that improve patient outcomes by integrating complex drug delivery devices, diagnostic systems, and medical technologies. With a global presence spanning over 30 facilities across three continents, Phillips Medisize serves pharmaceutical, biotechnology, and medtech companies by offering comprehensive, end-to-end services.

From concept design to large-scale production, the company leverages its deep expertise in human-centred design, engineering, and regulatory compliance to develop cutting-edge products. As a proven contract development and manufacturing organisation (CDMO), Phillips Medisize is dedicated to advancing healthcare innovations that save lives and improve the quality of life for patients worldwide.

Key Products and Services

• Drug Delivery Devices: Autoinjectors, pen injectors, inhalation devices, wearable drug delivery systems, and combination products.
• Diagnostics: Point-of-care testing devices and laboratory diagnostic systems.
• Medtech Solutions: Minimally invasive surgical devices, implantable devices, and handheld medical tools.
• Integrated Services: Concept design, engineering, clinical prototyping, regulatory support, and large-scale manufacturing.
• Proprietary Technologies: Advanced design and manufacturing platforms for custom solutions.

Phillips Medisize combines innovation, precision, and customer-centricity to address the evolving challenges of the healthcare industry. With its commitment to quality, sustainability, and patient-focused solutions, the company continues to drive transformative advancements in drug delivery, diagnostics, and medtech, setting new standards in global healthcare manufacturing.